Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.

How has the bartonellosis market grown over the years?

Over recent years, the size of the bartonellosis market has seen fast-paced growth. It is projected to expand from $1.17 billion in 2024 up to $1.31 billion in 2025, boasting a compound annual growth rate (CAGR) of 12.0%. Factors attributing to this growth during the historical period include a rise in reported cases of Bartonella disease, increased expenditure in healthcare, an upswing in funds dedicated to research and development, a growing incidence of transmissible ailments, and a heightened prevalence of infectious diseases.

What Is the forecasted market size and growth rate for the bartonellosis market?

In the forthcoming years, the bartonellosis market is anticipated to witness swift expansion. The market is projected to escalate to $2.03 billion by 2029, with an 11.7% compound annual growth rate (CAGR). The growth during this forecast period is linked to the escalating cases of zoonotic diseases, enhanced awareness of the disease, an increasing population of pet owners, a heightened focus on personalized medicine, and a rise in the understanding of cat scratch disease. The forecast period is also expected to see significant trends including developments in medical technology and biotechnology, the introduction of combined testing methods, progress in diagnostic techniques, and continued research and development initiatives.

Get your bartonellosis market report here!

https://www.thebusinessresearchcompany.com/report/bartonellosis-global-market-report

What are the major factors driving growth in the bartonellosis market?

The escalation of zoonotic disease instances is anticipated to spur the expansion of the bartonellosis market. Zoonotic diseases, which are transferred from animals to humans either directly or via vectors, are escalating due to a mix of factors like an increase in human-animal interaction, environmental modifications, deforestation, global travel and cross-species pathogen transmission. Bartonellosis aptly illustrates how zoonotic diseases work, acting as a prime representative of bacterial pathogens transmitting through animal vectors such as fleas, ticks, and lice, thereby causing a variety of clinical manifestations in humans and underlining the significance of understanding vector-borne disease dynamics in public health. For example, the Government of Canada reported in January 2023 that the number of submitted rabies samples had risen to 159 in November 2022, an increase from the 135 samples in October 2022. Consequently, the escalation in zoonotic disease instances is fuelling the growth of the bartonellosis market.

What key areas define the segmentation of the global bartonellosis Market?

The bartonellosis market covered in this report is segmented –

1) By Disease Type: Cat Scratch Disease (CSD), Trench Fever, Bartonella Endocarditis, Other Disease Types

2) By Diagnostic Method: Polymerase Chain Reaction (PCR) Testing, Serological Testing, Culture Methods, Histological Testing

3) By Treatment: Antibiotics, Antibacterial Agents, Supportive Care

4) By End-User: Hospitals And Clinics, Diagnostic Laboratories, Other End-Users

Subsegments:

1) By Cat Scratch Disease (CSD): Immunocompetent Hosts, Immunocompromised Hosts, Neurological Complications

2) By Trench Fever: Acute Trench Fever, Chronic Trench Fever, Asymptomatic Infections

3) By Bartonella Endocarditis: Native Valve Endocarditis, Prosthetic Valve Endocarditis, Bloodstream Infections

4) By Other Disease Types: Bacillary Angiomatosis, Parinaud’s Oculoglandular Syndrome, Bartonella-associated Vasculitis

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21111&type=smp

What are the top market players propelling the growth of the bartonellosis industry?

Major companies operating in the bartonellosis market are Mayo Clinic Laboratories, Northwell Health Labs, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, IDEXX Laboratories Inc., Bio-Rad Laboratories Inc., Alberta Precision Laboratories, Jiangsu BioPerfectus Technologies Co. Ltd., ARUP Laboratories, Surmodics Inc., Medical Diagnostic Laboratories LLC, Creative Biolabs, IGeneX Inc., Karius Inc., Synnovis Group LLP, Galaxy Diagnostics Inc., Gold Standard Diagnostics, Eurofins Biomnis, AMMAGENOMICS Private Limited, Ringbio

What key trends are currently impacting the bartonellosis market’s development?

Leading businesses in the bartonellosis market are putting significant emphasis on fundraising activities to enhance early detection and improve treatment modalities for the disease. The process of fundraising entails efforts made by organizations to generate funds that aid in the research, diagnosis, and treatment, as well as measures for bartonellosis prevention. This greatly contributes to driving innovation and widening the reach of healthcare solutions for the illness. For example, in April 2022, the Global Lyme Alliance (GLA), an American nonprofit body, initiated a crowdfunding campaign intent on generating $300,000 for innovative research on Bartonella, a latent pathogen, known to trigger severe health complications including neuroinflammation and psychiatric conditions. This drive was synchronized with Lyme disease awareness month and is aimed at augmenting knowledge about Bartonella’s conduct within the human physiology, which is pivotal for creating more potent treatments for Bartonella infections and associated diseases like Lyme. The campaign underlines the necessity for escalated awareness and fundraising endeavors to support individuals afflicted by these incapacitating diseases.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21111

What regions are dominating the bartonellosis market growth?

North America was the largest region in the bartonellosis market in 2024. The regions covered in the bartonellosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Insulin Biosimilars Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/insulin-biosimilars-global-market-report

Insulin Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/insulin-drugs-global-market-report

Asthma Drugs Global Market Report 2025

https://thebusinessresearchcompany.com/report/asthma-drugs-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: